phase 2 only
#retatrutide 2026-05-02
- gradient_greg — low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom, ask me again in a month 18:04
- noct.titrate — quick one buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely 18:30
- gradient_greg — reconstituted the 30 vial to 10mg/ml specifically so i could take 1.7 without measuring crumbs, ill dig out the number 18:47
- VialBot — Inter-lab diff for lot B-0114: 98.6% vs 98.1%. Within expected range. 19:18
- non_scale_win — stepping in 7.5 increments instead of doubling is the only thing i would change if i started again 19:54
sat at 12 for 6 months rather than climbing and it kept working, so i never went up
appetite suppression at 15 was stronger than my tirzepatide experience at a comparable point
smaller steps here
low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom, ask me again in a month
held at 15 for 14 months and it never plateaued for me, which i cant explain
triple agonist yeah
the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me
i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind
quick one buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely
came off at 14 weeks because my resting rate stayed elevated and i didnt like it
TRIUMPH is phase 3
reconstituted the 30 vial to 10mg/ml specifically so i could take 1.7 without measuring crumbs, ill dig out the number
genuine question blood pressure stayed flat for me while heart rate moved, which i didnt expect
back after 24 months, has anything actually been published since
Inter-lab diff for lot B-0114: 98.6% vs 98.1%. Within expected range.
held mine ages
the purity spread across lots worries me more than the molecule does
stepping in 7.5 increments instead of doubling is the only thing i would change if i started again
the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial, we shall see
phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
while im here the honest position is this has less human evidence behind it than anything else discussed here
glucagon is the new bit
how slow is low and slow here, four weeks a step or longer
anyone tracking blood pressure alongside the heart rate
there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
no long term data
right so did anyone come off because of the heart rate
my resting rate went up 5 bpm in the first month and came back most of the way by month 24
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
settled by month three
mine went up too
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me
the heart rate thing is real enough that i mention it whenever someone asks about starting
[edited]